$PFE
Pfizer IncToday's range · Low → High
Price · 1Y
Volume
Key stats
- Market cap
- 137.76B
- P/E (TTM)
- 18.47
- EPS (TTM)
- 1.31
- Beta
- 0.29
- 52-week high
- $28.75
- 52-week low
- $23.11
- Dividend yield
- 7.09%
- Day's range
- $24.095 – $24.41
- Prev close
- $24.25
Picks tagged $PFE
Recent news
- Yahoo· 5 hours ago
Is Pfizer on Track to Launch Its Next Lipitor -- This Time in the Weight-Loss Market?
- Yahoo· 7 hours ago
Pfizer (PFE) Gets An Opening In ATTR CM After AstraZeneca Trial Failure
- Yahoo· 9 hours ago
Sector Update: Healthcare Stocks Decline Late Afternoon
- Yahoo· 9 hours ago
Why Verizon, Clorox and More Dividend Stocks Are Flashing a Buy Signal
- Yahoo· 12 hours ago
Pfizer Poised for Mixed Second Quarter, RBC Says
- Yahoo· 12 hours ago
How a Rival's Clinical Setback Sent BBIO Stock to a 52-Week High
- Yahoo· 12 hours ago
Will Pfizer (PFE) Beat Estimates Again in Its Next Earnings Report?
- Yahoo· 13 hours ago
U.S. FDA Approves PADCEV® plus Keytruda® as Neoadjuvant and Adjuvant Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility
- Benzinga· 14 hours ago
B of A Securities Maintains Neutral on Pfizer, Lowers Price Target to $26
- Benzinga· 15 hours ago
Pfizer, Astellas Expand PADCEV-Keytruda Label With FDA Nod In Bladder Cancer
About
- IPO
- 1944-01-17
- Country
- US
- Currency
- USD
- Shares outstanding
- 5.70B
- Exchange
- NEW YORK STOCK EXCHANGE, INC.
- Industry
- Pharmaceuticals
Data from Finnhub. Quotes may be delayed up to 15 minutes. Not financial advice.